Tissue Engineering and Disease Modeling

Symposium Chair

4D printed nano biomaterials: Applications for on-demand drug delivery, improved tissue growth, stem cell delivery, and so much more
Thomas J. Webster
Chief Scientific Advisor, Interstellar Therapeutics

Key Speakers

3D Bioprinting for High-Content Tissue Engineering
Yu Shrike Zhang
Professor, Harvard Medical School

A Novel, Scalable, and Versatile Biocidal Surface Modification Technology to Prevent and Mitigate Biofilm Formation: An In-Vivo Safety and Efficacy Study
Houssam Bouloussa
Co-founder, DeBogy Molecular, Inc

Bacterial and human cell-synthesized metal nanomaterials: turning bacterial pathogens and human cells into clinical assets
David Medina Cruz
Co-founder, SynCell Biotechnology

Biomimetic Nanofiber-Enabled Rapid Creation of Skin Grafts
Hongjun Wang
Professor, Stevens Institute of Technology

Tissue engineering encompasses aspects of cells, materials, and biochemical, and physiochemical cues to restore, maintain, or replace tissue function. Disease modeling, whether it be in vitro or in vivo, aims to establish systems that resemble human diseases to improve our understanding of the mechanism of diseases or develop new therapies and diagnostic tools. Though these two areas are distinctly different in their end goals, there is significant conceptual and design overlap. Presentations in this session focus all aspects of tissue engineering or disease modeling including biomaterials, cells, growth factors, mechanical stimuli, and in vivo models and testing.

Back to Top ↑ 2023 Symposium Sessions
9:00	Tissue Engineering
4:00	Tissue Engineering - Posters

2023 Symposium Program
	Monday June 19

9:00	Tissue Engineering	Chesapeake 12
	Session chair: Thomas Webster, Interstellar Therapeutics, US
9:00	A Novel, Biocidal and Permanent Surface Modification Technology to Protect Medical and Non-Medical Surfaces H. Bouloussa, DeBogy Molecular, Inc., US
9:25	Bacterial and human cell-synthesized metal nanomaterials: turning bacterial pathogens and human cells into clinical assets D. Medina Cruz, SynCell Biotechnology, US
9:50	Design of Biomimetic ECM-like Matrices for Guided Tissue Formation H. Wang, Stevens Institute of Technology, US
10:15	Break
10:25	Converged Biofabrication Technologies for High-Content Tissue Model Engineering Y. Shrike Zhang, Harvard Medical School, US
10:50	Human Clinical Tissue Engineering Trials T.J. Webster, Interstellar Therapeutics, US
11:10	Gelatin Methacryloyl Granular Hydrogels: High-throughput Microgel Fabrication, Lyophilization, Chemical Assembly, and 3D Bioprinting A. Sheikhi, The Pennsylvania State University, US
11:30	Absolute Quantification of Genomic Targets for Cell Counting M. Cauble, H-J He, J. Almeida, S. Sarkar, National Institute of Standards and Technology, US
11:50	Light Transmission Aggregometry Method to Measure Tumor Cell Cluster Dissociation B. Schnoor, R.K. Kottana, A.L. Papa, George Washington University, US

4:00	Tissue Engineering - Posters	Expo Hall AB
	Developing Customizable Scaffolds with Antimicrobial Properties for Vascular Tissue Regeneration using Low Temperature Plasma (LTP) K. Vig, Alabama State University, US